Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,628.00    -94.00 (-1.99%)
Bid:
4,622.00
Ask:
4,628.00
Spread: 6.00 (0.13%)
Market Cap: £17.48b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

7 Sep 2010 17:53

RNS Number : 3142S
Halma PLC
07 September 2010
 



HALMA p.l.c.

 

DIRECTORS' AND PDMR'S SHARE TRANSACTIONS

 

 

Halma has received notifications in respect of Adam Meyers and Neil Quinn, Directors, and John Campbell, PDMR, relating to their beneficial interests in the ordinary shares of the Company.

 

Adam Meyers and John Campbell have beneficial interests held through the Halma Holdings Inc. Profit Sharing Savings Retirement Plan (the 'Plan'). This is a unitised, US Dollar denominated 401(k) plan and dividends paid on the Plan's assets are re-invested for the benefit of members. As a result of the final dividend paid by the Company on 25 August 2010 at the rate of 5.19p per share, the interests held by each of them increase as follows:

 

 

ADAM MEYERS

 

Shares acquired as a result of the Plan dividend re-investment

Increased holding through the Plan

 

 

 

95

 5,012

 

 

In addition to the above, Adam Meyers also has a direct beneficial interest in Halma ordinary shares. After the above transaction, the total beneficial holding of Adam Meyers in the ordinary shares of the Company increases to 182,892 shares (0.0485% of the issued ordinary share capital excluding treasury shares).

 

 

 

JOHN CAMPBELL

 

Shares acquired as a result of the Plan dividend re-investment

Increased holding through the Plan

 

 

 

 

238

12,623

 

 

In addition to the above, John Campbell also has a direct beneficial interest in Halma ordinary shares. After the above transaction, the beneficial holding of John Campbell, including family interests, in the ordinary shares of the Company increases to 144,865 shares (0.0384% of the issued ordinary share capital excluding treasury shares).

 

 

NEIL QUINN

 

At a Meeting of the Share Plans Committee of the Board of Halma p.l.c. held on 07 September 2010, 63,800 additional ordinary shares in the Company were allotted under the provisions of the Company's Share Option Plans to Neil Quinn, a Director, following his exercise of a share option. The exercise price was 163.50 pence per share.

Following the share option exercise Neil Quinn sold 63,800 shares on 07 September 2010 at 281.4365 pence per share. After the above transactions, the beneficial holding of Neil Quinn, including family interests, in the ordinary shares of Halma p.l.c. remains at 218,689 shares (0.0580% of the issued ordinary share capital).

 

Following the issue of ordinary shares as a result of the share options exercised on 07 September 2010, the issued ordinary share capital of the Company, excluding treasury shares, increases to 376,931,518 shares.

 

 

 

For further information, please contact:

 

Andrew Williams +44 (0)1494 721111 Chief Executive, Halma p.l.c.

 

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQDLFBBKFEBBF
Date   Source Headline
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results
15th Nov 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.